Found: 67
Select item for more details and to access through your institution.
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 3, p. 963, doi. 10.3892/ijo.2014.2804
- By:
- Publication type:
- Article
Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 2, p. 163, doi. 10.1093/jjco/hyab178
- By:
- Publication type:
- Article
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01909-7
- By:
- Publication type:
- Article
Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and efficacy of daratumumab in Japanese patients with relapsed or refractory multiple myeloma: a multicenter, phase 1, dose-escalation study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 4, p. 398, doi. 10.1007/s12185-015-1750-z
- By:
- Publication type:
- Article
Successful salvage therapy using lenalidomide in a patient with relapsed multiple myeloma after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 755, doi. 10.1111/bjh.16720
- By:
- Publication type:
- Article
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/ RPS6 KA3 signalling axis in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 534, doi. 10.1111/bjh.14707
- By:
- Publication type:
- Article
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 745, doi. 10.1111/hepr.13761
- By:
- Publication type:
- Article
Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128662
- By:
- Publication type:
- Article
Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Depressive symptoms during the first month of chemotherapy and survival in patients with hematological malignancies: A prospective cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi- scid, IL-2Rγ mouse lymphoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1791, doi. 10.1007/s00262-010-0905-2
- By:
- Publication type:
- Article
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi- scid, IL-2Rγ<sup>null</sup> mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1195, doi. 10.1007/s00262-008-0632-0
- By:
- Publication type:
- Article
Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.
- Published in:
- Liver International, 2017, v. 37, n. 8, p. 1138, doi. 10.1111/liv.13349
- By:
- Publication type:
- Article
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 14, p. 1, doi. 10.1002/cam4.70019
- By:
- Publication type:
- Article
Low‐dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6815
- By:
- Publication type:
- Article
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 13135, doi. 10.1002/cam4.5996
- By:
- Publication type:
- Article
Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse model.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 3, p. 219, doi. 10.1111/ejh.12231
- By:
- Publication type:
- Article
Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 8, p. 531, doi. 10.1016/j.clml.2024.03.012
- By:
- Publication type:
- Article
Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradation.
- Published in:
- Journal of Biochemistry, 2024, v. 175, n. 3, p. 253, doi. 10.1093/jb/mvad085
- By:
- Publication type:
- Article
Periplocin and cardiac glycosides suppress the unfolded protein response.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89074-x
- By:
- Publication type:
- Article
Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.
- Published in:
- International Journal of Cancer, 2009, v. 125, n. 1, p. 212, doi. 10.1002/ijc.24351
- By:
- Publication type:
- Article
Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2019, v. 59, n. 3, p. 135, doi. 10.3960/jslrt.19011
- By:
- Publication type:
- Article
Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2018, v. 58, n. 1, p. 39, doi. 10.3960/jslrt.17035
- By:
- Publication type:
- Article
Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 5, p. 647, doi. 10.1007/s12185-023-03633-8
- By:
- Publication type:
- Article
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 6, p. 900, doi. 10.1007/s12185-023-03550-w
- By:
- Publication type:
- Article
Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutation.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 2, p. 283, doi. 10.1007/s12185-022-03453-2
- By:
- Publication type:
- Article
A novel RARA–SNX15 fusion in PML–RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 6, p. 956, doi. 10.1007/s12185-022-03421-w
- By:
- Publication type:
- Article
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 4, p. 563, doi. 10.1007/s12185-022-03379-9
- By:
- Publication type:
- Article
Expression of activated integrin β7 in multiple myeloma patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 2, p. 219, doi. 10.1007/s12185-020-03013-6
- By:
- Publication type:
- Article
Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 424, doi. 10.1002/hon.3108
- By:
- Publication type:
- Article
Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 442, doi. 10.1002/hon.3105
- By:
- Publication type:
- Article
Clinical significance of tryptophan catabolism in follicular lymphoma.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 742, doi. 10.1002/hon.2804
- By:
- Publication type:
- Article
Potent antitumor effect of combination therapy with sub‑optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma.
- Published in:
- Oncology Letters, 2018, v. 15, n. 6, p. 9450, doi. 10.3892/ol.2018.8501
- By:
- Publication type:
- Article
Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemialike features.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1116418
- By:
- Publication type:
- Article
Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8-Selective Inhibitors.
- Published in:
- ChemMedChem, 2014, v. 9, n. 3, p. 657, doi. 10.1002/cmdc.201300414
- By:
- Publication type:
- Article
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4267, doi. 10.1111/cas.15556
- By:
- Publication type:
- Article
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).
- Published in:
- Cancer Science, 2021, v. 112, n. 12, p. 5011, doi. 10.1111/cas.15158
- By:
- Publication type:
- Article